← Airsculpt Technologies, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($2.2m) | $7.6m | $10.6m | ($14.7m) | ($4.5m) | ($8.3m) | ($11.7m) | — | |
| Depreciation and amortization | $5.0m | $5.6m | $6.6m | $8.1m | $10.3m | $11.9m | $12.8m | $12.6m | |
| Non-cash interest expense; amortization of debt costs | $226k | $211k | $639k | $921k | $207k | $339k | $525k | — | |
| Deferred income taxes | $0 | $0 | $208k | $1.1m | $1.3m | ($252k) | ($5.9m) | ($5.9m) | |
| Loss on impairment of long-lived assets | — | — | — | — | ($212k) | $16k | $4.6m | — | |
| Accounts payable | $1.9m | ($1.0m) | $1.6m | $865k | ($206k) | $739k | $579k | $3.4m | |
| Property and equipment included in accounts payable and accrued expenses | $0 | $0 | $255k | $1.1m | $283k | $1.6m | $1.6m | — | |
| Deferred revenue and patient deposits | $1.8m | $45k | ($423k) | ($452k) | ($896k) | ($293k) | $735k | — | |
| Accrued and other liabilities | $392k | $1.1m | $4.8m | $8.2m | $2.2m | $7.6m | ($6.8m) | — | |
| Prepaid expense and other current assets | ($1.8m) | $275k | ($3.8m) | ($5k) | $466k | ($2.1m) | ($4.4m) | — | |
| Other assets | ($635k) | ($204k) | ($1.3m) | ($7.3m) | ($3.8m) | ($1.0m) | $6.7m | — | |
| Net cash used in operating activities | $4.9m |
$14.0m
+182.64%
|
$26.6m
+90.82%
|
$24.4m
-8.21%
|
$24.0m
-2.01%
|
$11.3m
-52.62%
|
$3.1m
-72.72%
|
$7.5m
+142.22%
|
|
| Purchases of property and equipment, net | ($4.4m) | ($3.7m) | ($7.1m) | ($12.9m) | ($9.9m) | ($14.0m) | ($2.4m) | ($554k) | |
| Net cash used in investing activities | ($4.4m) | ($3.7m) | ($7.1m) | ($12.9m) | ($9.9m) | ($14.0m) | ($2.4m) | ($554k) | |
| Payments for debt modification | — | — | — | $0 | $0 | ($136k) | ($393k) | — | |
| Dividends paid to shareholders | — | $0 | $0 | ($23.2m) | ($385k) | ($252k) | $0 | $0 | |
| Other financing activity | — | $0 | $0 | ($147k) | ($569k) | ($954k) | $0 | — | |
| Net cash used in financing activities | ($783k) |
($5.0m)
-540.74%
|
($4.5m)
+9.33%
|
($27.3m)
-499.19%
|
($13.4m)
+50.87%
|
$630k
+104.70%
|
($478k)
-175.87%
|
$4.2m
+976.99%
|
|
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Equity-based compensation | $341k | $325k | $7.2m | $29.5m | $18.2m | $3.8m | $2.3m | — | |
| Cost related to closing location | — | — | — | — | $0 | $0 | $2.2m | — | |
| Taxes receivable | — | $0 | $0 | ($2.8m) | $890k | ($1.1m) | $1.6m | — | |
| Payments on term loan | ($500k) | ($2.9m) | ($838k) | ($84.3m) | ($12.1m) | ($2.1m) | ($13.8m) | — | |
| Payments on revolving credit facility | — | — | — | — | $0 | $5.0m | ($5.0m) | — | |
| Proceeds from public offerings, net | — | — | — | — | $0 | $0 | $18.8m | — | |
| Distribution to member | ($283k) | ($4.6m) | ($66.9m) | ($1.2m) | ($79k) | $0 | $0 | — | |
| Payment of taxes withheld through vested equity-based compensation | — | $0 | $0 | ($2.0m) | ($233k) | ($903k) | ($56k) | — | |
| Net decrease in cash and cash equivalents | ($284k) | $5.3m | $15.0m | ($15.7m) | $646k | ($2.0m) | $214k | — | |
| Beginning of period | $5.1m | $10.4m | $25.3m | $9.6m | $10.3m | $8.2m | $8.4m | — | |
| Cash paid for interest | $2.7m | $2.3m | $4.3m | $5.8m | $6.3m | $6.0m | $5.6m | — |